Continuation of Dialogue
VIII Annual Conference State Regulation and Russian Pharmaceutical Industry – 2016: Continuation of Dialogue” organized by the Association of Russian Pharmaceutical Manufacturers (ARPM), Association of International Pharmaceutical Manufacturers (AIPM), Analytical Company DSM Group and Research Institute of Healthcare and medical Management Organisation, Moscow Healthcare Department, was held in Moscow last week.
It is for a few years, that this professional site collects interested representatives of pharmaceutical industry and regulators and experts of pharmaceutical industry to discuss the most topical issues and draw attention to regulation of the developing united market of EEU.
The conference was opened by session “New regulatory basis regulating drug circulation and its enforcement in the EEU market”. Its participants discussed the new drug regulatory basis and its us in the EEU market. In particular, the issues discussed included mechanisms of mutual recognition of drug registration, legal provision of integration processes in the sphere of drug circulation and legalization of parallel import of pharmaceutical products at EEU, inspection of manufacturing sites.
During discussion of compulsory licensing issues, the forum participants came to a conclusion that it should only be used in exceptional cases, if it is impossible to come to an agreement with the manufacturer on supply of the drug required to save human lives. The need for accurate regulation of the mechanism was discussed.
A round table on issues on good pharmacovigilance practice was held within the framework of the conference.